Xcell Therapeutics Hits Upper Limit...Celemics·QuadMedicine ↑[K-Bio Pulse]

• 김승권
• 2026.02.06
• 오전 08:00

"CartiLife Continuous Hyaline Cartilage Growth 20 Months On"

• 김진수
• 2026.02.05
• 오후 04:37

ASF outbreak lifts Komipharm...Biodyne gains spotlight[K-Bio Pulse]

• 나은경
• 2026.02.05
• 오전 08:10

• 팜이데일리

Celemics hits limit before after hours filing[K-Bio Pulse]

• 나은경
• 2026.02.04
• 오전 08:00

• NGeneBio
• BLPharmtech
• NEUROPHET
• K-BioPulse
• pham

Bio Stocks Unfazed by ‘Black Monday’ Rout...Neurophet and BL Pharmtech Surge [K-Bio Pulse]

• 유진희
• 2026.02.03
• 오전 08:00

Huons Signs Distribution Agreement with Rappeler for Vitamin C and G6PD Diagnostic Devices

• 신민준
• 2026.02.02
• 오후 05:20

• K-biopulse
• PharmEdaily

ABL Bio Slides on Sanofi Reprioritization...Stock Specific Risks Hit Biotechs[K-Bio Pulse]

• 김새미
• 2026.02.02
• 오전 08:10

• Celltrion
• Aptozma
• PharmEdaily

Celltrion, Inc. Completes EU Launch of 'Aptozma'

• 김새미
• 2026.01.30
• 오전 10:44

CellBioN, Quracle Spark Commercialization Hopes[K-bio Pulse]

• 김지완
• 2026.01.30
• 오전 08:10

BL PharmTech hits five straight limit ups...GemVax extends rally [K-bio pulse]

• 김진수
• 2026.01.29
• 오전 08:00